Knowledge and Misconceptions Regarding SLE Among Medical Students at King Abdulaziz University

  • Yasser M. Bawazir Department of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.
  • Ibtisam Jali Department of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.

Abstract

Objective: The aim of this study was to assess the knowledge and misconceptions regarding SLE in sixth-year medical students in order to verify their understanding of the general aspects of SLE and provide recommendations to improve their learning experience.
Methods: We created a two-part 25-item questionnaire of 25 questions to assess students’ knowledge about epidemiology, clinical manifestations, complications, management, and prognosis of SLE, preferred ways of learning, and opinion on which specialties should include learning about the disease. The questionnaire was distributed to the participants through Google Forms.
Results: A total of 200 students from King Abdulaziz University responded to the questionnaire. The prevalence of adequate knowledge among students was 39.5%. There was a significant statistical difference between students with adequate knowledge and those without adequate knowledge according to the number of cases seen during training. There was a higher prevalence of adequate knowledge among female students and those who had a family history of SLE. Most students answered correctly the basic questions about SLE, while there were weak points in the questions about epidemiology and clinical manifestations. The preferred way of learning about SLE indicated by most respondents was to see patients in the wards and analyze the pathophysiology, diagnosis, and treatment of the disease. Most students chose internal medicine and rheumatology as specialties that should include learning about SLE.
Conclusion: The findings reflect the need to improve the teaching of chronic medical diseases treated on an outpatient basis and to modify the medical school curriculum so as to prepare future physicians to deal with such cases.
share this Article by

References

1. Di Battista M, Marcucci E, Elefante E, et al. One year in review 2018: systemic lupus erythematosus. Clin Exp Rheumatol. 2018;36(5):763-777.
2. Sebastiani GD, Prevete I, Iuliano A, Minisola G. The importance of an early diagnosis in systemic lupus erythematosus. Isr Med Assoc J. 2016;18(3-4):212-215.
3. Rees F, Doherty M, Grainge MJ, Lanyon P, Zhang W. The worldwide incidence and prevalence of systemic lupus erythematosus: a systematic review of epidemiological studies. Rheumatology (Oxford). 2017;56(11):1945-1961.
4. Al-Arfaj AS, Al-Balla SR, Al-Dalaan AN, et al. Prevalence of systemic lupus erythematosus in central Saudi Arabia. Saudi Med J. 2002;23(1):87-89.
5. Kerezoudis P, Lontos K, Apostolopoulou A, et al. Lupus in medical education: student awareness of basic, clinical, and interdisciplinary aspects of complex diseases. J Contemp Med Educ. 2016;4(3):97-106.
6. Emanuel EJ. Reforming American medical education. Milbank Q. 2017;95(4):692-697.
7. Oliveira Franco RL, Martins Machado JL, Satovschi Grinbaum R, Martiniano Porfírio GJ. Barriers to outpatient education for medical students: a narrative review. Int J Med Educ. 2019;10:180-190.
8. Sims GN, Jr., Smith HR. Outpatient management of systemic lupus erythematosus. Cleve Clin J Med. 1996;63(2):94-100. doi: 10.1097/BOR.0000000000000480
9. Smolen JS, Landewé RBM, Bijlsma JWJ, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. Ann Rheum Dis. 2019;79(6):685-699. doi: 10.1136/annrheumdis-2019-216655
10. Fanouriakis A, Kostopoulou M, Alunno A, et al. 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus. Ann Rheum Dis. 2019;78(6):736-745. doi: 10.1136/annrheumdis-2019-215089
11. Costedoat-Chalumeau N, Houssiau FA. Ustekinumab: a promising new drug for SLE? Lancet. 2018;392(10155):1284-1286. doi: 10.1016/S0140-6736(18)32330-4
12. Morand EF, Furie R, Tanaka IN, et al. Trial of anifrolumab in active systemic lupus erythematosus. N Engl J Med. 2020;382(3):211-221. doi: 10.1056/NEJMoa1912196
13. Mok CC. The Jakinibs in systemic lupus erythematosus: progress and prospects. Expert Opin Investig Drugs. 2019;28(1):85-92. doi: 10.1080/13543784.2019.1551358
14. Moroni G, Ponticelli C. Pregnancy in women with systemic lupus erythematosus (SLE). Eur J Intern Med. 2016;32:7-12. doi: 10.1016/j.ejim.2016.04.005
15. Bernatsky S, Boivin J-F, Joseph L, et al. Mortality in systemic lupus erythematosus. Arthritis Rheum. 2006;54(8):2550-2557. doi: 10.1002/art.21955
16. Tan TC, Fang H, Magder LS, Petri M. Differences between male and female systemic lupus erythematosus in a multiethnic population. J Rheumatol. 2012;39(4):759-769. doi: 10.3899/jrheum.111061
17. Alam A. How do medical students in their clinical years perceive basic sciences courses at King Saud University? Ann Saudi Med. 2011;31(1):58-61. doi: 10.4103/0256-4947.75780
Published
2021-08-26
How to Cite
BAWAZIR, Yasser M.; JALI, Ibtisam. Knowledge and Misconceptions Regarding SLE Among Medical Students at King Abdulaziz University. Journal of Contemporary Medical Sciences, [S.l.], v. 7, n. 4, aug. 2021. ISSN 2413-0516. Available at: <http://www.jocms.org/index.php/jcms/article/view/1059>. Date accessed: 16 sep. 2021. doi: https://doi.org/10.22317/jcms.v7i4.1059.